This inventor holds 3 USPTO granted patents. Top assignee: Sandoz Gmbh. Active years: 1984-1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1984-1989
Title: The Innovations of Hans Buhlmann
Introduction
Hans Buhlmann is a notable inventor based in Nuremberg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative preparations for treating hypertension and migraines. With a total of 3 patents to his name, Buhlmann's work has had a meaningful impact on medical treatments.
Latest Patents
Buhlmann's latest patents include a pharmaceutical preparation comprising co-dergocrine and a calcium antagonist. This preparation is designed to treat hypertension and migraines through the co-administration of its components. The formulations are defined to ensure effective treatment outcomes for patients suffering from these conditions.
Career Highlights
Hans Buhlmann is currently associated with Sandoz GmbH, a leading company in the pharmaceutical industry. His work at Sandoz has allowed him to focus on developing innovative solutions that address critical health issues. Buhlmann's expertise in pharmaceutical preparations has positioned him as a key figure in his field.
Collaborations
Buhlmann collaborates with Dieter Welzel, a fellow professional in the pharmaceutical sector. Their partnership has contributed to the advancement of their research and the development of effective pharmaceutical solutions.
Conclusion
Hans Buhlmann's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare. His patents reflect a dedication to addressing significant medical challenges, particularly in the treatment of hypertension and migraines.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile